AN2 Therapeutics, Inc. Common Stock Shares Outstanding

Quick Answer

AN2 Therapeutics, Inc. reported Common Stock Shares Outstanding of 27.41 million shares for the year ending 2025.

  • AN2 Therapeutics, Inc. showed a decrease of -8.4% in Common Stock Shares Outstanding from 2024 to 2025.
  • This data is from AN2 Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 17, 2026.
  • XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2021 to 2025), AN2 Therapeutics, Inc.'s Common Stock Shares Outstanding has grown by 904.0%.
  • Historical annual values: Fiscal year 2025: 27.41 million shares | Fiscal year 2024: 29.92 million shares | Fiscal year 2023: 29.74 million shares | Fiscal year 2022: 19.40 million shares | Fiscal year 2021: 2.73 million shares.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: